Glutathione and antioxidant enzymes serve complementary roles in protecting activated hepatic stellate cells against hydrogen peroxide-induced cell death

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2027-2034

  Dunning, Sandra ^a   ur Rehman, Atta ^a   Tiebosch, Marjolein H ^a   Hannivoort, Rebekka A ^a   Haijer, Floris W ^a   Woudenberg, Jannes ^a   van den Heuvel, Fiona A J ^a   Buist Homan, Manon ^a   Faber, Klaas Nico ^a   Moshage, Han ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Catalase; Cell death; Glutathione peroxidase; Oxidative stress; Superoxide dismutase

Indexed keywords

ACRIDINE ORANGE; BUTHIONINE SULFOXIMINE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; HYDROGEN PEROXIDE; MESSENGER RNA; SUPEROXIDE DISMUTASE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LIVER NECROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; STELLATE CELL; WESTERN BLOTTING;

EID: 84882757943     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.07.008     Document Type: Article

References (44)

1. Lee K.S., Lee S.J., Park H.J., Chung J.P., Han K.H., Chon C.Y., Lee S.I., Moon Y.M. Oxidative stress effect on the activation of hepatic stellate cells. Yonsei Med. J. 2001, 42:1-8.
2. Lee K.S., Buck M., Houglum K., Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J. Clin. Invest. 1995, 96:2461-2468.
3. Zamara E., Novo E., Marra F., Gentilini A., Romanelli R.G., Caligiuri A., Robino G., Tamagno E., Aragno M., Danni O., Autelli R., Colombatto S., Dianzani M.U., Pinzani M., Parola M. 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J. Hepatol. 2004, 40:60-68.
4. Ke B., Buelow R., Shen X.D., Melinek J., Amersi F., Gao F., Ritter T., Volk H.D., Busuttil R.W., Kupiec-Weglinski J.W. Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum. Gene Ther. 2002, 13:1189-1199.
5. Kisseleva T., Cong M., Paik Y., Scholten D., Jiang C., Benner C., Iwaisako K., Moore-Morris T., Scott B., Tsukamoto H., Evans S.M., Dillmann W., Glass C.K., Brenner D.A. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9448-9453.
6. Gao B., Seki E., Brenner D.A., Friedman S., Cohen J.I., Nagy L., Szabo G., Zakhari S. Innate immunity in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G516-G525.
7. Brenner D.A. Molecular pathogenesis of liver fibrosis. Trans. Am. Clin. Climatol. Assoc. 2009, 120:361-368.
8. Kisseleva T., Brenner D.A. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J. Gastroenterol. Hepatol. 2007, 22(Suppl. 1):S73-S78.
9. Kossakowska A.E., Edwards D.R., Lee S.S., Urbanski L.S., Stabbler A.L., Zhang C.L., Phillips B.W., Zhang Y., Urbanski S.J. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am. J. Pathol. 1998, 153:1895-1902.
10. Sato S., Adachi A., Wakamatsu K., Sasaki Y., Satomura K., Asano G. Abnormal elastic system fibers in fibrotic human liver. Med. Electron Microsc. 2000, 33:135-142.
11. Younossi Z.M., Stepanova M., Negro F., Hallaji S., Younossi Y., Lam B., Srishord M. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 2012, 91:319-327.
12. Kisseleva T., Brenner D.A. Hepatic stellate cells and the reversal of fibrosis. J. Gastroenterol. Hepatol. 2006, 21(Suppl. 3):S84-S87.
13. Kisseleva T., Uchinami H., Feirt N., Quintana-Bustamante O., Segovia J.C., Schwabe R.F., Brenner D.A. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 2006, 45:429-438.
14. Taura K., Miura K., Iwaisako K., Osterreicher C.H., Kodama Y., Penz-Osterreicher M., Brenner D.A. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 2010, 51:1027-1036.
15. Chu A.S., Diaz R., Hui J.J., Yanger K., Zong Y., Alpini G., Stanger B.Z., Wells R.G. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology 2011, 53:1685-1695.
16. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin. Liver Dis. 2001, 21:311-335.
17. Tuchweber B., Desmouliere A., Bochaton-Piallat M.L., Rubbia-Brandt L., Gabbiani G. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab. Invest. 1996, 74:265-278.
18. Beaussier M., Wendum D., Schiffer E., Dumont S., Rey C., Lienhart A., Housset C. Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab. Invest. 2007, 87:292-303.
19. Yang Z.F., Tsui T.Y., Ho D.W., Tang T.C., Fan S.T. Heme oxygenase-1 potentiates the survival of small-for-size liver graft. Liver Transpl. 2004, 10:784-793.
20. Colell A., Garcia-Ruiz C., Miranda M., Ardite E., Mari M., Morales A., Corrales F., Kaplowitz N., Fernandez-Checa J.C. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 1998, 115:1541-1551.
21. Parola M., Marra F., Pinzani M. Myofibroblast-like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. Mol. Aspects Med. 2008, 29:58-66.
22. Bosselut N., Housset C., Marcelo P., Rey C., Burmester T., Vinh J., Vaubourdolle M., Cadoret A., Baudin B. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics 2010, 10:1017-1028.
23. Hannivoort R.A., Dunning S., Vander Borght S., Schroyen B., Woudenberg J., Oakley F., Buist-Homan M., van den Heuvel F.A., Geuken M., Geerts A., Roskams T., Faber K.N., Moshage H. Multidrug resistance-associated proteins are crucial for the viability of activated rat hepatic stellate cells. Hepatology 2008, 48:624-634.
24. Chen Y., Choi S.S., Michelotti G.A., Chan I.S., Swiderska-Syn M., Karaca G.F., Xie G., Moylan C.A., Garibaldi F., Premont R., Suliman H.B., Piantadosi C.A., Diehl A.M. Hedgehog controls hepatic stellate cell fate by regulating metabolism. Gastroenterology 2012, 143. (1319-29.e1-11).
25. Jaeschke H., Bautista A.P., Spolarics Z., Spitzer J.J. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic. Res. Commun. 1991, 15:277-284.
26. Jaeschke H., Benzick A.E., Smith C.V., Mitchell J.R. The pathophysiological significance of reactive oxygen formation in rat liver. Adv. Exp. Med. Biol. 1991, 283:295-298.
27. Wolff J.A., Budker V. The mechanism of naked DNA uptake and expression. Adv. Genet. 2005, 54:3-20.
28. Jaeschke H., Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am. J. Physiol. 1991, 260:G355-G362.
29. Jaeschke H., Farhood A., Smith C.W. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am. J. Physiol. 1991, 261:G1051-G1056.
30. Bautista A.P. Acute ethanol binge followed by withdrawal regulates production of reactive oxygen species and cytokine-induced neutrophil chemoattractant and liver injury during reperfusion after hepatic ischemia. Antioxid. Redox Signal. 2002, 4:721-731.
31. Jaeschke H., Smith C.W. Mechanisms of neutrophil-induced parenchymal cell injury. J. Leukoc. Biol. 1997, 61:647-653.
32. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine 1989, Clarendon Press, Oxford and New York.
33. Miao L., St Clair D.K. Regulation of superoxide dismutase genes: implications in disease. Free Radic. Biol. Med. 2009, 47:344-356.
34. White C.W., Nguyen D.H., Suzuki K., Taniguchi N., Rusakow L.S., Avraham K.B., Groner Y. Expression of manganese superoxide dismutase is not altered in transgenic mice with elevated level of copper-zinc superoxide dismutase. Free Radic. Biol. Med. 1993, 15:629-636.
35. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
36. Copin J.C., Gasche Y., Chan P.H. Overexpression of copper/zinc superoxide dismutase does not prevent neonatal lethality in mutant mice that lack manganese superoxide dismutase. Free Radic. Biol. Med. 2000, 28:1571-1576.
37. Tsan M.F. Superoxide dismutase and pulmonary oxygen toxicity: lessons from transgenic and knockout mice (Review). Int. J. Mol. Med. 2001, 7:13-19.
38. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 1995, 11:376-381.
39. Kinnula V.L., Crapo J.D. Superoxide dismutases in malignant cells and human tumors. Free Radic. Biol. Med. 2004, 36:718-744.
40. Dhar S.K., Tangpong J., Chaiswing L., Oberley T.D., St Clair D.K. Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages. Cancer Res. 2011, 71:6684-6695.
41. Sarsour E.H., Venkataraman S., Kalen A.L., Oberley L.W., Goswami P.C. Manganese superoxide dismutase activity regulates transitions between quiescent and proliferative growth. Aging Cell 2008, 7:405-417.
42. Rahman I., MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur. Respir. J. 2000, 16:534-554.
43. Mari M., Morales A., Colell A., Garcia-Ruiz C., Fernandez-Checa J.C. Mitochondrial glutathione, a key survival antioxidant. Antioxid. Redox Signal. 2009, 11:2685-2700.
44. Zhong Q., Putt D.A., Xu F., Lash L.H. Hepatic mitochondrial transport of glutathione: studies in isolated rat liver mitochondria and H4IIE rat hepatoma cells. Arch. Biochem. Biophys. 2008, 474:119-127.